Subjects showing persistent hyperglycemia ( glycated hemoglobin [ HbA1c ] 8 % and 12 % ) were then randomly assigned to CSII or continuing an MDI regimen for a 6-month phase followed by a single crossover of the MDI arm , switching to CSII .